Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
The speaker will highlight the urgent and growing global threat posed by antimicrobial resistance (AMR) in tuberculosis (TB) and other non-tuberculous mycobacterial (NTM) infections. This talk will address the major challenges in developing new therapeutic strategies to target the varied physiological states of these resilient pathogens and their exceptional ability to evade host defence mechanisms across human, animal, and environmental settings, within biofilm-forming microbiomes. Drawing on recent research findings, the seminar will discuss the validation of novel therapeutic targets that could accelerate drug design and discovery efforts. In particular, it will highlight promising work on the repurposing of carprofen, a non-steroidal anti-inflammatory drug, to help reverse drug resistance in TB and NTM diseases.
This interdisciplinary seminar is designed to engage a broad audience, including researchers in basic science, public health professionals, clinicians, and industry experts, all united by a shared interest in tackling one of the most pressing health threats of our time.
